Adagio Medical (ADGM) vs 20/20 Biolabs (AIDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
20/20 Biolabs is the larger company by market cap ($4.8 million vs $3.5 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADGM | AIDX |
|---|---|---|
| Share price | $0.13 | $0.379 |
| Market cap | $3.53M | $4.84M |
| 1-day change | -2.84% | +10.33% |
| EPS (TTM) | $-1.37 | $-0.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.58 | $50.00 |
| 52-week low | $0.12 | $0.33 |
| Distance from 52-week high | -94.97% | -99.24% |
| Analyst consensus | none | none |
| Avg. price target upside | +2461.54% | +1219.26% |
| Average volume | 9.07M | 90.86K |
| Shares outstanding | 27.19M | 12.77M |
| Employees | 41 | 4 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Adagio Medical
ADGM stock →Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia.
Healthcare · Medical Devices · 41 employees
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Healthcare · Medical Devices · 4 employees
ADGM vs AIDX FAQ
Which is bigger, Adagio Medical or 20/20 Biolabs?
20/20 Biolabs (AIDX) is larger, with a market capitalization of $4.84M compared with $3.53M for Adagio Medical (ADGM).
Are Adagio Medical and 20/20 Biolabs in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.